Atezolizumab 1.875g/15ml solution for injection vials
NHS hospitals in England used £90,153,184 of indicative cost of Atezolizumab 1.875g/15ml solution for injection vials in the 12 months to July 2026, about 0.3% of all hospital medicines spend. That is up 22.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Atezolizumab 1.875g/15ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Atezolizumab 1.875g/15ml solution for injection vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £14,187,453 |
| The Christie Nhs Foundation Trust | £6,941,419 |
| Royal Surrey County Hosp Nhs Found Trust | £3,546,239 |
| Hull And East Yorkshire Hpls Nhs Trust | £2,836,729 |
| Royal Free London Nhs Foundation Trust | £2,733,921 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £2,589,229 |
| James Paget Univ Hospitals Nhs Ft | £2,299,845 |
| Leeds Teaching Hpls Nhs Trust | £2,120,883 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £1,861,960 |
| South Tyneside And Sunderland Nhs Ft | £1,827,691 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.